Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection
Clicks: 360
ID: 270964
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
360 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #2 of 3 articles by views in internal medicine (tokyo, japan)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Links between hepatitis C virus (HCV) infection and several non-Hodgkin lymphomas have been suggested by epidemiological studies. We herein report the first documented case of a patient with HCV-associated Hodgkin lymphoma who showed a marked regression following interferon-based antiviral therapy. …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (40 words).
Try re-searching for a better abstract.
| Reference Key |
k2012internalregression
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Takahashi K;Nishida N;Kawabata H;Haga H;Chiba T;; |
| Journal | internal medicine (tokyo, japan) |
| Year | 2012 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
male
case reports
middle aged
Remission Induction
Tomography
x-ray computed
antiviral agents / therapeutic use*
ribavirin / therapeutic use
recombinant proteins / therapeutic use
chronic / drug therapy*
interferon-alpha / therapeutic use
polyethylene glycols / therapeutic use
chronic / complications*
pmid:23037466
doi:10.2169/internalmedicine.51.8404
ken takahashi
naoshi nishida
tsutomu chiba
hodgkin disease / complications*
hodgkin disease / diagnostic imaging
hodgkin disease / drug therapy*
hodgkin disease / pathology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.